ARTICLE | Company News
Aveo Pharmaceuticals cancer news
July 22, 2013 7:00 AM UTC
Aveo disclosed in an SEC filing that on July 3 it received a subpoena from the SEC seeking documents related to cancer candidate tivozanib. The company, which said it intends to fully cooperate with the "fact-finding" inquiry, is not providing additional comment. ...